SAN DIEGO, CA - Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN), unveiled today its operational plan for its "Super-Incubator" stem cell company.
Month 1-2: Assembly of Team. Regen intends to assemble a team of world-class leaders in the spheres of Technology, Intellectual Property assessment, valuation...
Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine. - Regen BioPharma Unveils Plan for Value Optimization of Nascent Stem Cell Patents
May 03, 2012 at 08:49 AM EDT
